-
公开(公告)号:US20230330237A1
公开(公告)日:2023-10-19
申请号:US18023696
申请日:2021-08-27
发明人: Weizhou Zhang , Guangrong Zheng , Daohong Zhou , Yufeng Xiao , Lei Wang
摘要: Modulators of Nuclear Receptor Subfamily 4 Group A Member 1 (NR4A1) are described as well as their use as therapeutic agents for disease, disorders, or symptoms thereof, including those where modulation of NR4A1 is implicated. Such disease and disorders include cancer.
-
公开(公告)号:US11788056B2
公开(公告)日:2023-10-17
申请号:US17213619
申请日:2021-03-26
发明人: Roy Curtiss, III , Shifeng Wang
CPC分类号: C12N1/36 , A61K39/0275 , A61K39/08 , A61P31/04 , C12N15/74 , A61K2039/522 , A61K2039/523 , A61K2039/542
摘要: Described herein are compositions and methods for making and using recombinant bacteria that are capable of regulated attenuation and/or regulated expression of one or more antigens of interest.
-
公开(公告)号:US20230313230A1
公开(公告)日:2023-10-05
申请号:US18059269
申请日:2022-11-28
CPC分类号: C12N15/86 , C12N7/00 , C12Q1/701 , C12N2750/14143 , C12N2750/14152 , C12Q2600/158
摘要: Provided herein are methods related to co-packaging of multiple rAAV particles, e.g., by introducing multiple nucleic acid vectors encoding proteins or polypeptides or RNAs of interest into a single cell preparation.
-
公开(公告)号:US20230293899A1
公开(公告)日:2023-09-21
申请号:US18018734
申请日:2021-07-28
IPC分类号: A61N1/40
CPC分类号: A61N1/40
摘要: A method is provided for precision dosing of electrical stimulation of the brain. The method includes determining a location of each voxel of a plurality of voxels in a reference frame of an electro-stimulation device including a plurality of electrodes positioned on a head of a subject. The method also includes obtaining measurements that indicate a tissue type at each voxel inside the head of the subject based on an imaging device. The method also includes determining, with a processor, a value of one or more parameters of the electro-stimulation device based on the tissue type measurements at each voxel such that the electro-stimulation device is configured to generate a value of one or more parameters of an electric field at each voxel inside the head of the subject to improve the treatment outcome of the subject.
-
公开(公告)号:US20230293607A1
公开(公告)日:2023-09-21
申请号:US18120670
申请日:2023-03-13
IPC分类号: A61K35/747 , A61K9/00 , A61K9/19 , A61K47/10 , A61K47/46
CPC分类号: A61K35/747 , A61K9/0053 , A61K9/19 , A61K47/10 , A61K47/46
摘要: A composition is provided herein directed to a mixture of one or more Lactobacillus sp. and a phenolic compound. In a specific embodiment, disclosed is a Lactobacillus/phenol mixture that has been lyophilized to form a Lactobacillus/phenol lyophilized mixture. The Lactobacillus/phenol mixture of Lactobacillus/phenol lyophilized mixture may be packaged in a capsule, emulsion, or tablet such that the Lactobacillus are protected in a gastrointestinal tract for transport to an intestine of a subject. In another embodiment, a method for treating indigestion, abdominal pain or cephalic syndrome in a subject including orally administering to the subject a composition comprising an effective amount of Lactobacillus/phenol mixture or lyophilized mixture. In still a further embodiment, of improving immune function in a subject, comprising administering to the subject, the composition comprising an effective amount of Lactobacillus/phenol mixture or lyophilized mixture.
-
公开(公告)号:US11739130B2
公开(公告)日:2023-08-29
申请号:US17204627
申请日:2021-03-17
CPC分类号: C07K14/4703 , A61K9/0048 , A61K48/005 , A61K38/00 , A61K48/00 , C07K2319/02 , C07K2319/03 , C07K2319/10 , C12N15/86 , C12N2740/15041 , C12N2750/14141
摘要: The present invention provides methods and compositions for treating and/or preventing age related macular degeneration and other conditions involving macular degeneration, ocular neovascularization, or ocular inflammation. In an exemplary embodiment, a method is disclosed that involves administering an expression vector that delivers a secretable and cell penetrating CARD to a subject in need of treatment or prevention of age-related macular degeneration or another condition involving macular degeneration or ocular neovascularization.
-
公开(公告)号:US20230263808A1
公开(公告)日:2023-08-24
申请号:US18007308
申请日:2021-10-13
摘要: The present invention provides methods for treating and ameliorating symptoms of skeletal muscle cachexia and related conditions, including muscle wasting and muscle weakness.
-
公开(公告)号:US11730734B2
公开(公告)日:2023-08-22
申请号:US16332211
申请日:2017-09-12
IPC分类号: A61K31/4965 , A61P31/22 , A61K31/439 , A61K31/497 , A61K31/5377 , A61K31/5517 , A61K31/505 , A61K31/4745 , A61K31/5355 , A61K31/4709 , A61K45/06 , A61K31/36
CPC分类号: A61K31/4965 , A61K31/36 , A61K31/439 , A61K31/4709 , A61K31/4745 , A61K31/497 , A61K31/505 , A61K31/5355 , A61K31/5377 , A61K31/5517 , A61K45/06 , A61P31/22
摘要: The invention relates to kinase inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating or preventing herpesvirus infection and/or herpesvirus-associated diseases and disorders.
-
39.
公开(公告)号:US20230250480A1
公开(公告)日:2023-08-10
申请号:US18015169
申请日:2021-07-09
发明人: Kevin Ka W. WANG , Zhihui YANG , Michael D. WEISS
IPC分类号: C12Q1/6883 , G01N33/573 , G01N33/68
CPC分类号: C12Q1/6883 , G01N33/573 , G01N33/6893 , C12Q2600/158 , C12Q2600/178 , G01N2800/2871 , G01N2333/916
摘要: The invention relates to a combination or panel of HIE-relevant protein and/or microRNA (miRNA) biomarkers that are released from injured tissues into biofluids such as blood in HIE, and their use as markers for detection of HIE. A selected panel of blood-based protein and/or miRNA HIE biomarkers that are measured at more than one time interval can aid in the diagnosis of HIE severity, and to determine the prognosis of poor versus good cognitive or overall patient outcome.
-
公开(公告)号:US20230233708A1
公开(公告)日:2023-07-27
申请号:US17918887
申请日:2021-04-13
发明人: Keyun Qing , Arun Srivastava
IPC分类号: A61K48/00
CPC分类号: A61K48/0041 , A61K48/0058
摘要: Disclosed herein are novel methods for administration of rAAV particles having enhanced transduction properties, comprising the pre-incubation and co-administration of AAV capsids and polyvinyl alcohol (PVA). The disclosed methods of rAAV particle administration have improved efficiency in transducing mammalian liver and hematopoetic cells in vivo. The disclosed methods are suitable for use with a variety of AAV capsid serotypes and presudotypes and improve vector potency, thus lowering the concentration of rAAV particle required to achieve the desired effect. Further disclosed herein are buffers for storage and manufacturing of rAAV particles comprising PVA.
-
-
-
-
-
-
-
-
-